Role of lycopene in smoke-promoted chronic obstructive pulmonary disease and lung carcinogenesis

Jelena Mustra Rakic,Xiang-Dong Wang

DOI: https://doi.org/10.1016/j.abb.2020.108439

IF: 4.114

2020-08-01

Archives of Biochemistry and Biophysics

Abstract:<p>Chronic obstructive pulmonary disease (COPD) and lung cancer are a major cause of morbidity and mortality worldwide, with cigarette smoking being the single most important risk factor for both. Emerging evidence indicate alterations in reverse cholesterol transport-mediated removal of excess cholesterol from lung, and intracellular cholesterol overload to be involved in smoke-promoted COPD and lung cancer development. Since there are currently few effective treatments for COPD and lung cancer, it is important to identify food-derived, biologically active compounds, which can protect against COPD and lung cancer development. High intake of the carotenoid lycopene, as one of phytochemicals, is associated with a decreased risk of chronic lung lesions. This review article summarizes and discusses epidemiologic evidence, <em>in vitro</em> and <em>in vivo</em> studies regarding the prevention of smoke-promoted COPD and lung carcinogenesis through dietary lycopene as an effective intervention strategy. We focus on the recent research implying that lycopene preventive effect is through targeting the main genes involved in reverse cholesterol transport. This review also indicates gaps in knowledge about the function of lycopene against COPD and lung cancer, offering directions for further research.</p>

biochemistry & molecular biology,biophysics